Molecular characterization of human AML cells with resistance to growth-inhibitory and apoptotic effects of hydroxamic acid analogue histone deacetylase inhibitors.

被引：0
|
作者：
Guo, F
Sigua, C
Bali, P
Fiskus, W
Sondarva, G
Annavarapu, S
Mouttaki, A
Atadja, P
Bhalla, KN
机构：
[1] H Lee Moffit Canc Ctr & Res Inst, Tampa, FL USA
[2] Novartis Pharmaceut, Cambridge, MA USA
来源：
BLOOD | 2004年 / 104卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1171
引用
收藏
页码：332A / 332A
页数：1
相关论文
共 22 条
  • [1] Differential transcriptional regulation of microRNAs, in ovarian cancer cells, by two distinct hydroxamic acid histone deacetylase inhibitors.
    Nageli, Kaleb
    Yoon, Seung Nam
    Thomson, J. Michael
    Reilly, Elizabeth
    Chen, Ching-Shih
    Hammond, Scott
    Nephew, Kenneth
    Balch, Curtis
    CANCER RESEARCH, 2009, 69
  • [2] Growth inhibition of renal cancer cells by histone deacetylase inhibitors, suberoylanilide hydroxamic acid (SAHA) and PXD101
    Min, Gyeong Eun
    Hwang, Jung Jin
    Yoo, Changhee
    Kim, Mi-Joung
    Kim, Yong-Sook
    Song, Kanghyon
    Kim, Seong Cheol
    Kwon, Taek Min
    Park, Jong Yeon
    Ahn, Tai Young
    Kim, Choung-Soo
    JOURNAL OF UROLOGY, 2008, 179 (04): : 40 - 40
  • [3] Suberoylanilide hydroxamic acid, a histone deacetylase inhibitor:: Effects on gene expression and growth of glioma cells in vitro and in vivo
    Yin, Dong
    Ong, John M.
    Hu, Jinwei
    Desmond, Julian C.
    Kawamata, Norihiko
    Konda, Bindu M.
    Black, Keith L.
    Koeffler, H. Phillip
    CLINICAL CANCER RESEARCH, 2007, 13 (03) : 1045 - 1052
  • [4] Molecular features linked to the growth-inhibitory effects of gemcitabine on human pancreatic cancer cells
    Toshimitsu, Hiroaki
    Iizuka, Norio
    Yamamoto, Kohtaro
    Kawauchi, Shigeto
    Oga, Atsunori
    Furuya, Tomoko
    Oka, Masaaki
    Sasaki, Kohsuke
    ONCOLOGY REPORTS, 2006, 16 (06) : 1285 - 1291
  • [5] The histone deacetylase inhibitors suberoylanilide hydroxamic (Vorinostat) and valproic acid induce irreversible and MDR1-independent resistance in human colon cancer cells
    Fedier, Andre
    Dedes, Konstantin J.
    Imesch, Patrick
    Von Bueren, Andre O.
    Fink, Daniel
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2007, 31 (03) : 633 - 641
  • [6] Histone deacetylase inhibitor, suberoylanilide hydroxamic acid (Vorinostat, SAHA) profoundly inhibits the growth of human pancreatic cancer cells
    Kumagai, Takashi
    Wakimoto, Naoki
    Yin, Dong
    Gery, Sigal
    Kawamata, Norihiko
    Takai, Noriyuki
    Komatsu, Naoki
    Chumakov, Alexy
    Imai, Yasufumi
    Koeffler, H. Phillip
    INTERNATIONAL JOURNAL OF CANCER, 2007, 121 (03) : 656 - 665
  • [7] Synergistic effects of combined treatment with histone deacetylase inhibitor suberoylanilide hydroxamic acid and TRAIL on human breast cancer cells
    Zhou, Weiqiang
    Feng, Xiuyan
    Han, Han
    Guo, Shanchun
    Wang, Guangdi
    SCIENTIFIC REPORTS, 2016, 6
  • [8] Synergistic effects of combined treatment with histone deacetylase inhibitor suberoylanilide hydroxamic acid and TRAIL on human breast cancer cells
    Weiqiang Zhou
    Xiuyan Feng
    Shanchun Han Han
    Guangdi Guo
    Scientific Reports, 6
  • [9] The histone deacetylase inhibitor, suberoylanilide hydroxamic acid, overcomes resistance of human breast cancer cells to Apo2L/TRAIL
    Butler, Lisa M.
    Liapis, Vasilios
    Bouralexis, Stelios
    Welldon, Katie
    Hay, Shelley
    Thai, Le M.
    Labrinidis, Agatha
    Tilley, Wayne D.
    Findlay, David M.
    Evdokiou, Andreas
    INTERNATIONAL JOURNAL OF CANCER, 2006, 119 (04) : 944 - 954
  • [10] Anticancer effects of the MHY218 novel hydroxamic acid-derived histone deacetylase inhibitor in human ovarian cancer cells
    Jeon, Heui Sook
    Ahn, Mee Young
    Park, Ji Hye
    Kim, Tae Hyung
    Chun, Pusoon
    Kim, Won Hee
    Kim, Jungsu
    Moon, Hyung Ryong
    Jung, Jee H.
    Kim, Hyung Sik
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2010, 37 (02) : 419 - 428
123